These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 21189159

  • 1. Rapid functional screening of effective siRNAs against Plk1 and its growth inhibitory effects in laryngeal carcinoma cells.
    Lan H, Zhu J, Ai Q, Yang Z, Ji Y, Hong S, Song F, Bu Y.
    BMB Rep; 2010 Dec; 43(12):818-23. PubMed ID: 21189159
    [Abstract] [Full Text] [Related]

  • 2. Silencing of polo-like kinase (Plk) 1 via siRNA causes inhibition of growth and induction of apoptosis in human esophageal cancer cells.
    Bu Y, Yang Z, Li Q, Song F.
    Oncology; 2008 Dec; 74(3-4):198-206. PubMed ID: 18714168
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Rational combinations of siRNAs targeting Plk1 with breast cancer drugs.
    Spänkuch B, Kurunci-Csacsko E, Kaufmann M, Strebhardt K.
    Oncogene; 2007 Aug 23; 26(39):5793-807. PubMed ID: 17369857
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Polo-like kinase 1 contributes to the tumorigenicity of BEL-7402 hepatoma cells via regulation of Survivin expression.
    He Z, Wu J, Dang H, Lin H, Zheng H, Zhong D.
    Cancer Lett; 2011 Apr 28; 303(2):92-8. PubMed ID: 21330050
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Plk1 is negatively regulated by RNF8.
    Yoshioka T, Kimura M, Saio M, Era S, Okano Y.
    Biochem Biophys Res Commun; 2011 Jun 24; 410(1):57-61. PubMed ID: 21635870
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A combination of a DNA-chimera siRNA against PLK-1 and zoledronic acid suppresses the growth of malignant mesothelioma cells in vitro.
    Kawata E, Ashihara E, Nakagawa Y, Kiuchi T, Ogura M, Yao H, Sakai K, Tanaka R, Nagao R, Yokota A, Takeuchi M, Kimura S, Hirai H, Maekawa T.
    Cancer Lett; 2010 Aug 28; 294(2):245-53. PubMed ID: 20206440
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Targeting Polo-like kinase in cancer therapy.
    Degenhardt Y, Lampkin T.
    Clin Cancer Res; 2010 Jan 15; 16(2):384-9. PubMed ID: 20068088
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.